レオロジー機能食品研究所

これまで研究開発と新たな発見

論文一覧

2024年 Lipid and Transcriptional Regulation in a Parkinson’s Disease Mouse Model by Intranasal Vesicular and Hexosomal Plasmalogen-Based Nanomedicines. Wu Y, Wang J, Deng Y, Angelov B, Fujino T, Hossain S, Angelova A. Adv. Healthcare Mater. 2304588, 2024
2023年 Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies. Wu Y, Angelov B, Deng Y, Fujino T, Hossain S, Drechsler M, Angelova A. Commun Chem 6 : 241, 2023
2023年 Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies. Wu Y, Angelov B, Deng Y, Fujino T, Hossain S, Drechsler M, Angelova A. Commun Chem 6 : 241, 2023
Orally Administered Plasmalogens Alleviate Psycho-behavioral Parameters in Patients with Depressive Disorder: An Observational Study. Obo T, Obo M, Fukuchi M, Sasuga Y, Fujino T, Kono S. Mega Journal of Case Reports, 2023
Plasmalogens inhibit neuroinflammation and promote cognitive function. S.Hossain,et,al. Brain Res Bull 192:56-61,2023
2022年 Plasmalogens, the vinyl ether-linked glycerophospholipids, enhance learning and memory by regulating brain-derived neurotrophic factor. Hossain S, Mawatari S, Fujino T. Front Cell Dev Biol 2022, 10:828282.
Plasmalogen-mediated activation of GPCR21 regulates cytolyty of NK cells against the target cells. S.Hossain,et al. J Immunol 209:310-325,2022
Decreases of ethanolamine plasmalogen and phosphatidylcholine in erythrocyte are a common phenomenon in Alzheimer’s,and coronary artery diseases. S.Mawatari,et al. Brain Res Bull 189:5-10,2022
2021年 Plasmalogen attenuates LPS-induced ICAM-1 expression in endothelial cell line. Kanda R, Iwasaki K, Yihao P, Umeda M, Fujino T, Kawazoe T. J Osaka Dent Univ 2021, 5:179-185.
2020年 Improvement of blood plasmalogens and clinical symptoms in Parkinson’s disease by oral administration of ether phospholipids: a preliminary report. S.Mawatari,et al. Parkinsons Dis 2020:2671070,2020
Identification of plasmalogens in Bifidobacterium longum,but not in Bifidobacterium animalis. S.Mawatari,et al. J Sci Rep 10:427,2020
2019年 Effects of plasmalogen on patients with moderate-to-severe Alzheimer’s disease and blood plasmalogen changes: a multi-center,open-label study. T.Fujino,et al. J Alzheimers Dis Parkinsonism 9:474,2019
2018年 Oral ingestion of plasmalogens can attenuate the LPS-induced memory loss and microglial activation. MS.Hossain,et al. Biochem Biophys Res Commun 496:1033-1039,2018
Enzymatic measurement of other phospholipids in human plasma after hydrolysis of plasma with phospholipase A1. S.Mawatari,at al. Pract Lab Med 10:44-51,2018

プラズマローゲンとは

これまで研究開発と新たな発見

アルツハイマー病型認知症とは